Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker
S. 5237IntroducedSenate · nowHousePresidentLawIn committee
Sec. 2 · S. 5237

Funding for antibiotic resistance clinical research

Read this section in the full bill →

This section appears in one version only, so there is nothing to compare yet.

(a) In general The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on— (1) supporting rapid recruitment of clinical trial participants; (2) conducting clinical trial recruitment outreach in community settings; (3) supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and (4) developing patient-reported outcomes in clinical studies. (b) Authorization of appropriations There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a).

Sec. 2: Funding for antibiotic resistance clinical research · Public Law Tracker